Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
about
The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design.Improving interMediAte risk management. MARK studyFramingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors.Randomised clinical trial of an intensive intervention in the primary care setting of patients with high plasma fibrinogen in the primary prevention of cardiovascular disease.Dietary habits in patients with ischemic stroke: a case-control study.Impact of a self-care education programme on patients with type 2 diabetes in primary care in the Basque Country.Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others.Prevalence of obesity and associated cardiovascular risk: the DARIOS study.Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine.Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, MalaysiaOriginal and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation studyComparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain.Estimation of 10-Year Risk of Coronary Heart Disease in Nepalese Patients with Type 2 Diabetes: Framingham Versus United Kingdom Prospective Diabetes StudyShort-term predictive ability of selected cardiovascular risk prediction models in a rural Bangladeshi population: a case-cohort studyPerformance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation studyDevelopment of appropriate coronary heart disease risk prediction models in HIV-infected patients.Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design.SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritisA Pilot Study to Assess the Feasibility of the Spanish Diabetes Self-Management Program in the Basque Country.Physical activity prescription by primary care nurses using health assets: Study design of a randomized controlled trial in patients with cardiovascular risk factors.Sex-related differences in abdominal obesity impact on ischemic stroke risk.Validation of a population coronary disease predictive system: the CASSANDRA model.Cardiovascular risk tables: opinion and degree of use of primary care doctors from Madrid, Spain.Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015.A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar Disorder.Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain.Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort.Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension.Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women.Predicting the onset of major depression in primary care: international validation of a risk prediction algorithm from Spain.Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies.Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.Validity of a method for the self-screening of cardiovascular risk.Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplantDetection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound
P2860
Q30476450-1FEE7F20-10A2-47BD-B099-8C8FAA275F0AQ31033555-4E19F1F6-6923-4AB0-846E-9DF08ACF7A98Q31139249-3A9D5F2B-645F-406A-8AF0-74DE28874752Q31162135-4A8C27EC-55D4-49EC-91BA-DFE8ED9867D8Q33726320-C0D8FDEC-AB6C-4599-B65A-8D137C298594Q34180573-4C75BA49-D16B-46E1-A56B-72094BF16E6EQ34702818-D0F0D517-F02E-4DB9-A352-A3C3952FD93CQ34746829-6B702E4D-7B63-401F-8177-9FE5942DDC61Q34755293-8D11012C-AB0F-4A6D-B042-DFAA80B16A9BQ34759380-8BF8C5EE-D60A-4CD7-8C63-F52BE67DB071Q34901444-4AEF4513-1BB7-4F0D-A382-D3B8495D35BCQ35187760-C5A44302-A264-43E2-8D4A-15F681D745F9Q35259627-FF88FE4C-622E-45B9-BA15-B00D3EEC17E3Q35805646-14772745-D7DB-4B30-88C7-86E7DD3CAA29Q35918503-2A7389BF-5D15-4A61-BE91-CEE9E00D0EB1Q36032312-AFA8CA9B-58DD-4234-9A5D-B0A7418C6953Q36069547-4C5D5F99-F32B-4DAF-BAEA-2D81DFA2F400Q36241155-3681E462-A6DC-416B-843C-C78E0B03FFBCQ37111718-49DE9E9C-0C07-4E12-A4CC-A14492D03A95Q37366209-3E97311C-FCDD-4D8E-AFBF-FBEE0FDE23A9Q37691093-1F8D3D43-BE8B-463C-9359-EAD1791E8645Q38381804-DD4F7044-595C-4972-9C66-045775E0AD55Q38842834-B03172F8-6B01-4D2A-9A88-F28C919FE88DQ39054698-B83055FA-B70E-40F4-B135-16CDE23E2008Q39233353-E447B2F6-D5D0-480D-B335-571F6B975FE5Q42628823-3C385703-6CF8-4BDA-BD29-AB022216F616Q45227773-22209DE4-75F2-4FBD-83B2-756D028B80A8Q46101552-FDF2E7AE-467D-4EA4-B6A2-8EC0AD30460CQ46958892-A291EA23-2B15-41EE-AB58-E36CF38FA6F1Q47657268-653B22B8-49F4-4B5A-B8FC-BC8FFD363DABQ48235029-1A773ABE-A02E-489C-BA34-023B634852D5Q49043410-3DE33AD7-30AE-4BCD-AF64-78C6A41EC444Q50446755-825BAE49-183E-4CE8-959B-2DE30F5498ADQ51374764-339B41C9-DBD9-40AD-842D-CFFF9BDF561BQ51581899-D4A1F920-1605-4138-B147-5CC16C6CB6F9Q51583909-8097DFD5-7E51-4048-AB9A-98741FEA5786Q51604005-10658A87-15B4-443F-9C13-B2FC3B0AD815Q55306767-6F709D8E-325F-41A8-8C6E-5316EB039191Q56243541-EF2DB512-392C-4483-B8DC-A12A7DEFC125Q58694922-8D125480-F823-44A5-B6C0-65E2B8A58B3F
P2860
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Validity of an adaptation of t ...... function: the VERIFICA Study.
@ast
Validity of an adaptation of t ...... function: the VERIFICA Study.
@en
type
label
Validity of an adaptation of t ...... function: the VERIFICA Study.
@ast
Validity of an adaptation of t ...... function: the VERIFICA Study.
@en
prefLabel
Validity of an adaptation of t ...... function: the VERIFICA Study.
@ast
Validity of an adaptation of t ...... function: the VERIFICA Study.
@en
P2093
P2860
P50
P356
P1476
Validity of an adaptation of t ...... function: the VERIFICA Study.
@en
P2093
Byung-Ho Nam
Carmen Cabezas
Ferran Cordón
Isaac Subirana
Pascual Solanas
Rafel Ramos
Ralph B D'Agostino
P2860
P356
10.1136/JECH.2005.038505
P577
2007-01-01T00:00:00Z